Cocrystal Pharma (COCP)
(Delayed Data from NSDQ)
$1.98 USD
+0.09 (4.76%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $1.93 -0.05 (-2.53%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Cocrystal Pharma, Inc. [COCP]
Reports for Purchase
Showing records 1 - 20 ( 35 total )
Company: Cocrystal Pharma, Inc.
Industry: Medical - Biomedical and Genetics
1Q24 Financial Results Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cocrystal Pharma, Inc.
Industry: Medical - Biomedical and Genetics
Multiple Clinical Data Catalysts This Year; 2023 Financials; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cocrystal Pharma, Inc.
Industry: Medical - Biomedical and Genetics
CC-42344 FDA Feedback; KSURF Agreements Terminated; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cocrystal Pharma, Inc.
Industry: Medical - Biomedical and Genetics
Merck Collaboration Terminated; Lowering PT to $10
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cocrystal Pharma, Inc.
Industry: Medical - Biomedical and Genetics
CC-42344 Phase 2a Trial Initiates Enrollment; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cocrystal Pharma, Inc.
Industry: Medical - Biomedical and Genetics
CC-42344 Featured at World Vaccine Congress; 3Q23 Financials; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cocrystal Pharma, Inc.
Industry: Medical - Biomedical and Genetics
CC-42344 Phase 2a Influenza Program Gets UK Green Light; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cocrystal Pharma, Inc.
Industry: Medical - Biomedical and Genetics
CDI-988 Phase 1 Trial Subject Dosing Initiated; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cocrystal Pharma, Inc.
Industry: Medical - Biomedical and Genetics
2Q23 Financial Results Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cocrystal Pharma, Inc.
Industry: Medical - Biomedical and Genetics
Oral Protease Inhibitor Selected as Norovirus Lead Candidate; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cocrystal Pharma, Inc.
Industry: Medical - Biomedical and Genetics
CDI-988 Australian Trial Authorization Granted; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cocrystal Pharma, Inc.
Industry: Medical - Biomedical and Genetics
Equity Raise Complete; 1Q23 Financials; Lowering PT to $12
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cocrystal Pharma, Inc.
Industry: Medical - Biomedical and Genetics
Financial Results Reported; Favorable Judgment in Litigation; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cocrystal Pharma, Inc.
Industry: Medical - Biomedical and Genetics
CC-42344 Clinical Data Appears Favorable; Modulating PT to $35
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cocrystal Pharma, Inc.
Industry: Medical - Biomedical and Genetics
CC-42344 Showcased at World Antiviral Congress; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cocrystal Pharma, Inc.
Industry: Medical - Biomedical and Genetics
CC-42344 Influenza Candidate Shows Clinical Safety; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cocrystal Pharma, Inc.
Industry: Medical - Biomedical and Genetics
CC-42344 Influenza Agent Progress; Reverse Stock Split; Raising PT to $42
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cocrystal Pharma, Inc.
Industry: Medical - Biomedical and Genetics
Antiviral Pipeline Progress; 2Q22 Financial Results; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cocrystal Pharma, Inc.
Industry: Medical - Biomedical and Genetics
Single Ascending Dose Portion of Phase 1 Trial Completed; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Cocrystal Pharma, Inc.
Industry: Medical - Biomedical and Genetics
NIAID Collaboration Expanded; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R